Similar articles for PMID: 28887051

Year	Number of Results
2003	1
2007	2
2009	1
2010	3
2011	1
2012	6
2013	4
2014	10
2015	14
2016	14
2017	17
2018	13
2019	6
2020	9
2021	6
2022	4
2023	4
2024	0

1

Senft D, Leiserson MDM, Ruppin E, Ronai ZA. Senft D, et al. Trends Mol Med. 2017 Oct;23(10):874-898. doi: 10.1016/j.molmed.2017.08.003. Epub 2017 Sep 5. Trends Mol Med. 2017. PMID: 28887051 Free PMC article. Review.

2

Repurposing Drugs in Oncology: Next Steps.

Verbaanderd C, Meheus L, Huys I, Pantziarka P. Verbaanderd C, et al. Trends Cancer. 2017 Aug;3(8):543-546. doi: 10.1016/j.trecan.2017.06.007. Epub 2017 Jul 12. Trends Cancer. 2017. PMID: 28780930

3

Disparity between Inter-Patient Molecular Heterogeneity and Repertoires of Target Drugs Used for Different Types of Cancer in Clinical Oncology.

Zolotovskaia MA, Sorokin MI, Petrov IV, Poddubskaya EV, Moiseev AA, Sekacheva MI, Borisov NM, Tkachev VS, Garazha AV, Kaprin AD, Shegay PV, Giese A, Kim E, Roumiantsev SA, Buzdin AA. Zolotovskaia MA, et al. Int J Mol Sci. 2020 Feb 26;21(5):1580. doi: 10.3390/ijms21051580. Int J Mol Sci. 2020. PMID: 32111026 Free PMC article.

4

Enabling Precision Oncology Through Precision Diagnostics.

Brown NA, Elenitoba-Johnson KSJ. Brown NA, et al. Annu Rev Pathol. 2020 Jan 24;15:97-121. doi: 10.1146/annurev-pathmechdis-012418-012735. Annu Rev Pathol. 2020. PMID: 31977297 Review.

5

Personalized Medicine: Genomics Trials in Oncology.

Hayes DF, Schott AF. Hayes DF, et al. Trans Am Clin Climatol Assoc. 2015;126:133-43. Trans Am Clin Climatol Assoc. 2015. PMID: 26330667 Free PMC article. Review.

6

Optimising translational oncology in clinical practice: strategies to accelerate progress in drug development.

Stahel R, Bogaerts J, Ciardiello F, de Ruysscher D, Dubsky P, Ducreux M, Finn S, Laurent-Puig P, Peters S, Piccart M, Smit E, Sotiriou C, Tejpar S, Van Cutsem E, Tabernero J. Stahel R, et al. Cancer Treat Rev. 2015 Feb;41(2):129-35. doi: 10.1016/j.ctrv.2014.12.004. Epub 2014 Dec 16. Cancer Treat Rev. 2015. PMID: 25533737 Free article. Review.

7

Precision medicine and oncology: an overview of the opportunities presented by next-generation sequencing and big data and the challenges posed to conventional drug development and regulatory approval pathways.

Doherty M, Metcalfe T, Guardino E, Peters E, Ramage L. Doherty M, et al. Ann Oncol. 2016 Aug;27(8):1644-6. doi: 10.1093/annonc/mdw165. Epub 2016 Apr 26. Ann Oncol. 2016. PMID: 27117532 Free article. No abstract available.

8

Genomics-driven oncology: framework for an emerging paradigm.

Garraway LA. Garraway LA. J Clin Oncol. 2013 May 20;31(15):1806-14. doi: 10.1200/JCO.2012.46.8934. Epub 2013 Apr 15. J Clin Oncol. 2013. PMID: 23589557 Review.

9

In Silico Oncology Drug Repositioning and Polypharmacology.

Cheng F. Cheng F. Methods Mol Biol. 2019;1878:243-261. doi: 10.1007/978-1-4939-8868-6_15. Methods Mol Biol. 2019. PMID: 30378081 Review.

10

Cancer drug development in China: recent advances and future challenges.

Wu YL, Zhang H, Yang Y. Wu YL, et al. Drug Discov Today. 2015 Jun;20(6):766-71. doi: 10.1016/j.drudis.2014.11.005. Epub 2014 Nov 20. Drug Discov Today. 2015. PMID: 25463037 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year